Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-039077

President and CEO sold 12,135 shares at $12.92 ($156,784)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Touchon Pascal President and CEO 2020-06-25 Sale −12,135 $12.92 $156,784 264,844 D
Open-market sales · 12,135 sh · avg $12.92 · $156,784
Loading xslF345X03/doc4.xml…